Hudson Pacific Properties to Participate in Citi’s 2026 Global Property CEO Conference

LOS ANGELES–(BUSINESS WIRE)–Hudson Pacific Properties, Inc. (NYSE: HPP) today announced that Victor Coleman, Chairman and Chief…

Albertsons® Companies Appoints Brian Rice to Board of Directors

Seasoned Global Technology Leader Brings Deep Digital, Data and AI Expertise BOISE, Idaho–(BUSINESS WIRE)–Albertsons® Companies, Inc.…

Four Feinstein Institutes Scientists Honored as National Academy of Inventors Senior Members

Lior Brimberg, Jared M. Huston, Stavros Zanos and Theodoros Zanos recognized for impactful innovations and patented…

Northpointe Bancshares, Inc. Announces Appointment of Rodney E. Hood to its Board of Directors

GRAND RAPIDS, Mich.–(BUSINESS WIRE)–#InvestorRelations–Northpointe Bancshares, Inc. (NYSE: NPB) (the “Company”), announced today that the Honorable Rodney…

Interface Reports Fourth Quarter and Full Year 2025 Results

Delivered record 2025 sales and profitability as One Interface strategy accelerates growth ATLANTA–(BUSINESS WIRE)–Interface, Inc. (Nasdaq:…

Tradlinx Releases New Report on the Future of SCM: From Visibility to an AI-Native ‘Reliable Partner’

SEOUL, South Korea–(BUSINESS WIRE)–#AI—Tradlinx, a global supply chain data platform, has unveiled a new report, “The…

Interface Increases Regular Quarterly Dividend

ATLANTA–(BUSINESS WIRE)–Interface, Inc. (Nasdaq: TILE), the global flooring and sustainability leader, today announced that its Board…

eClerx Wins Stevie® Awards at the 2026 Asia-Pacific Stevie Awards

NEW YORK–(BUSINESS WIRE)–#AI–eClerx Services Ltd (ECLERX.NS), a leading productized services company, today announced that it has…

Michael Karangelen, Former CEO of North America for Investindustrial ($10+bn AUM PE Firm), Joins Star Mountain Capital as Member of the Firm’s Executive and Investment Committees

NEW YORK–(BUSINESS WIRE)–Star Mountain Capital, LLC («Star Mountain»), a rapidly growing, employee-owned investment firm with ~$4.5…

Centauri Therapeutics Extends Series A to £30M With £6M Investment From AMR Action Fund to Support Progression of Lead Clinical Candidate

Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to…